1 / 19

The Value of Networking in Allergy & Asthma Research Judah A. Denburg, MD, FRCP(C)

The Value of Networking in Allergy & Asthma Research Judah A. Denburg, MD, FRCP(C) Scientific Director and CEO The Allergy Genes and Environment Network Genes & the Environment : The Genesis of Allergy and Asthma Workshop March 1-3, 2009, Vancouver, BC.

marin
Télécharger la présentation

The Value of Networking in Allergy & Asthma Research Judah A. Denburg, MD, FRCP(C)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Value of Networking in Allergy & Asthma Research Judah A. Denburg, MD, FRCP(C) Scientific Director and CEO The Allergy Genes and Environment Network Genes & the Environment : The Genesis of Allergy and Asthma Workshop March 1-3, 2009, Vancouver, BC

  2. Networks of Centres of ExcellenceMission Mobilize Canada’s research talent in the academic, private and public sectors and apply it to developing the economy and improving the quality of life of Canadians

  3. TL•NCE PENCE SFM AquaNet CGDN Wood-Pulps ISIS GEOIDE CIPI CBDN CANVAC IRIS CSN CAN Auto21 CLLRnet StemNet CWN CITR MITACS AllerGen HEALNet Micronet Why Canada Built Networks Vast country Dispersed institutions Link strengths Create critical mass

  4. Federal S&T Strategy • The Knowledge Advantage • The People Advantage • The Entrepreneurial Advantage

  5. Strategic Positioning of Network Investments

  6. Need for AllerGen NCE • Increase in allergic diseases, including asthma, prevalence: the “Atopic March” • ~40% of Canadians suffer from allergies • 1 in 12 Canadians have asthma – chronic • Allergy and asthma are major policy and public health issues in Canada • Research and development focused on impact in partnership with industry, healthcare, policy and not-for-profit sectors

  7. AllerGen’s VISION To create an enduringnetwork of allergy and immune disease experts whose discovery and development efforts contribute to reductions in the impact of allergic and related immune diseases nationally and globally.

  8. AllerGen’s MISSION To catalyze and support discovery, development, networking, capacity building, commercialization and knowledge translation that contribute to reducing the morbidity, mortality and socio-economic burden of allergic and related immune diseases.

  9. Networking: Making the connection • 30 academic institutions • 28 research institutes • 200 scientists • 300 trainees • 8 global foci • 7 provinces

  10. Six Key Accomplishments Clinical Investigator Collaborative (CIC) Canadian Healthy Infant Longitudinal Development (CHILD) Study Genomics and genetics research Food allergy research programme New training opportunities & partnerships International leadership (IPI programme)

  11. Integrated Programmatic Research Structure

  12. Integrated Programmatic Research Structure 2007-2012 CHILD CIC Biomarkers/Genetics Food Allergy Mind-Body Interactions Environmental Exposures Public Policy, Ethics & Law Occupational and Work-related allergy & asthma

  13. Networking and Partnerships Progress >250 partner organizations AllerGen leveraging of partner cash and in-kind contributions exceeds 1:1 target by >100% (2008)

  14. International Partnership Initiatives 5 new international partnerships facilitated by an NCE/IDRC pilot grant 2007-9 GA2LEN (Belgium/EU) IUALTD (France/ El Salvador/Mexico) Karolinska Institute (Sweden) St. John’s Institute (India) WHO/GARD/ARIA (Montpelier/Geneva) New, emerging international collaborations: Europe (GABRIEL), Germany (Humboldt/Helmholtz), Taiwan, China, Israel, USA

  15. A network of people • Building new relationships • industry • government • academia • not-for-profit • healthcare

  16. “Research is to see what everybody has seen and to think what nobody has thought." Albert Szent-Györgyi, 1937 Nobel Prize Winner, Physiology/ Medicine

More Related